Evidence map›Paper›PMID 20368649›Full record

Trial reportAnnals of internal medicine2010

Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III).

Paul D Stein, Thomas L Chenevert, Sarah E Fowler, Lawrence R Goodman, Alexander Gottschalk, Charles A Hales, Russell D Hull, Kathleen A Jablonski, Kenneth V Leeper, David P Naidich and 6 more

Registry-linked trialAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Annals of internal medicine, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02059551 (Diagnostic Performances of Magnetic Resonance Imaging Combined With Venous Ultrasonography of the Legs for Pulmonary Embolism), which is not on this map. Cited by 99 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02059551 nacompletednot on this mapstarted 2013, after this paper: background citation

Diagnostic Performances of Magnetic Resonance Imaging Combined With Venous Ultrasonography of the Legs for Pulmonary Embolism

TypeinterventionalSponsorAssistance Publique - Hôpitaux de ParisRan2013 to 2019Enrolled887ConditionsPulmonary EmbolismArmsMRI combined with venous ultrasonography of the legs
3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. SCMR Position Paper (2020) on clinical indications for cardiovascular magnetic resonance.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2020
    Guideline
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Pulmonary embolism consensus.Archivos de cardiologia de Mexico · 2026
    Article
  11. The Role of Non-invasive Tests in Pulmonary Embolism.Interventional cardiology (London, England) · 2025
    Review
  12. Article
  13. The History of Diagnosing Venous Thromboembolism.Seminars in thrombosis and hemostasis · 2024
    Review
  14. Review
  15. Article
  16. Review
  17. [Magnetic resonance imaging of the lung : State of the art].Radiologie (Heidelberg, Germany) · 2023
    Article
  18. Review
  19. Review
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Paul D SteinMichigan State University, College of Osteopathic Medicine, Department of Internal Medicine, Michigan State University Venous Thromboembolism Research Unit, St. Joseph-Mercy Oakland Hospital, 44405 Woodward Avenue, Pontiac, MI 48341-5023, USA. steinp@trinity-health.org
Thomas L Chenevert
Sarah E Fowler
Lawrence R Goodman
Alexander Gottschalk
Charles A Hales
Russell D Hull
Kathleen A Jablonski
Kenneth V Leeper
David P Naidich
Daniel J Sak
H Dirk Sostman
Victor F Tapson
John G Weg
Pamela K Woodard
PIOPED III (Prospective Investigation of Pulmonary Embolism Diagnosis III) Investigators

Funding

Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III)U01HL077155 · NHLBI · GEORGE WASHINGTON UNIVERSITY · PI FOWLER, SARAH E. · 2005 to 2008
$2.4M
Prospective Investigation for Pulmonary Embolism Dx IIIU01HL077358 · NHLBI · ST. JOSEPH MERCY OAKLAND · PI STEIN, PAUL D · 2005 to 2008
$1.8M
Prospective Investigation of Pulmonary Embolism Dx IIIU01HL077149 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HALES, CHARLES A · 2005 to 2008
$1.6M
Prospective Investigation of Pulmonary Embolism DX-IIU01HL081593 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NAIDICH, DAVID P · 2005 to 2008
$1.4M
Prospective Investigation of Pulmonary Embolism DX-IIIU01HL077154 · NHLBI · WASHINGTON UNIVERSITY · PI WOODARD, PAMELA K · 2005 to 2008
$978k
Prospective Investigation of Pulmonary Embolism Dx IIIU01HL077153 · NHLBI · EMORY UNIVERSITY · PI LEEPER, KENNETH V · 2005 to 2008
$903k
Prospective Investigation of Pulmonary Embolism Dx IIIU01HL077151 · NHLBI · UNIVERSITY OF CALGARY · PI HULL, RUSSELL D · 2005 to 2008
$688k
Prospective Investigation for Pulmonary Embolism Dx IIIU01HL081594 · NHLBI · ST. JOSEPH MERCY OAKLAND · PI SAK, DANIEL J · 2005 to 2008
$676k
NHLBI NIH HHS HL077149NHLBI NIH HHS HL077151NHLBI NIH HHS HL077153NHLBI NIH HHS HL077154NHLBI NIH HHS HL077155NHLBI NIH HHS HL077358NHLBI NIH HHS HL081593NHLBI NIH HHS HL081594NHLBI NIH HHS HL177150NHLBI NIH HHS U01 HL077149NHLBI NIH HHS U01 HL077151NHLBI NIH HHS U01 HL077153NHLBI NIH HHS U01 HL077154NHLBI NIH HHS U01 HL077155NHLBI NIH HHS U01 HL077358NHLBI NIH HHS U01 HL081593NHLBI NIH HHS U01 HL081594
6 · The paper itself

Abstract

backgroundThe accuracy of gadolinium-enhanced magnetic resonance pulmonary angiography and magnetic resonance venography for diagnosing pulmonary embolism has not been determined conclusively.

objectiveTo investigate performance characteristics of magnetic resonance angiography, with or without magnetic resonance venography, for diagnosing pulmonary embolism.

designProspective, multicenter study from 10 April 2006 to 30 September 2008.

setting7 hospitals and their emergency services. PATIENTS: 371 adults with diagnosed or excluded pulmonary embolism. MEASUREMENTS: Sensitivity, specificity, and likelihood ratios were measured by comparing independently read magnetic resonance imaging with the reference standard for diagnosing pulmonary embolism. Reference standard diagnosis or exclusion was made by using various tests, including computed tomographic angiography and venography, ventilation-perfusion lung scan, venous ultrasonography, d-dimer assay, and clinical assessment.

resultsMagnetic resonance angiography, averaged across centers, was technically inadequate in 25% of patients (92 of 371). The proportion of technically inadequate images ranged from 11% to 52% at various centers. Including patients with technically inadequate images, magnetic resonance angiography identified 57% (59 of 104) with pulmonary embolism. Technically adequate magnetic resonance angiography had a sensitivity of 78% and a specificity of 99%. Technically adequate magnetic resonance angiography and venography had a sensitivity of 92% and a specificity of 96%, but 52% of patients (194 of 370) had technically inadequate results. LIMITATION: A high proportion of patients with suspected embolism was not eligible or declined to participate.

conclusionMagnetic resonance pulmonary angiography should be considered only at centers that routinely perform it well and only for patients for whom standard tests are contraindicated. Magnetic resonance pulmonary angiography and magnetic resonance venography combined have a higher sensitivity than magnetic resonance pulmonary angiography alone in patients with technically adequate images, but it is more difficult to obtain technically adequate images with the 2 procedures.

Indexed as

GadoliniumAdultAgedFemaleHumansMagnetic Resonance AngiographyMaleMiddle AgedPhlebographyProspective StudiesPulmonary EmbolismReference StandardsSensitivity and SpecificityGadolinium

Identifiers

PMID20368649
PMCPMC3138428

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.